Literature DB >> 1153405

Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.

R R Gala, R S Boss.   

Abstract

The ability of 2 Br-alpha-ergocryptine (CB-154) to suppress serum prolactin levels was examined in animals under the influence of continuous estrogen stimulation. A single injection of polyestradiol phosphate (Estradurin) once every 21 days produced a constant elevation of serum prolactin. The simultaneous administration of 1 mg/day of CB-154 to estrogenized animals suppressed serum prolactin levels below that of Estradurin alone but the levels were significantly greater than those of animals receiving CB-154 alone. It was suggested that, while CB-154 prevents the release of prolactin, estrogen stimulates prolactin synthesis despite the block of its release. Ether anesthesia may be capable of partially overriding the block of CB-154 and released the stored hormone from the gland.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1153405     DOI: 10.3181/00379727-149-38800

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

1.  The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.

Authors:  S W Lamberts; M de Quijada; J G Klijn
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

2.  gamma-Glutamyl transpeptidase in rat mammary tissue. Activity during lactogenesis and regulation by prolactin.

Authors:  P A Pocius; C R Baumrucker; J P McNamara; D E Bauman
Journal:  Biochem J       Date:  1980-05-15       Impact factor: 3.857

3.  Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.

Authors:  N Shigaki; M Kimura; S Takano; N Fujino; M Akagi
Journal:  Jpn J Surg       Date:  1987-09

4.  Preventive effects of antioestrogen on mammary and pituitary tumorigenesis in rats.

Authors:  C Sumi; K Yokoro; R Matsushima
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

5.  17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.

Authors:  C W Welsch; C Adams; L K Lambrecht; C C Hassett; C L Brooks
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.